The evaluation for usefulness of serum AMH levels to predict ovulation in patients of primary ovarian insufficiency

The evaluation for usefulness of serum AMH levels to predict ovulation in patients of primary ovarian insufficiency - The evaluation for usefulness of serum AMH levels to predict ovulation in patients of primary ovarian insufficiency

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029464

Enrollment

Registered

2018-04-01

Start date

2017-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary ovarian insufficiency

Interventions

Measurement of serum AMH levels one time per menstruation cycle (total 6 cycles)

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Primary ovarian insufficiency or menopause under age 40

Exclusion criteria

Exclusion criteria: without desire for having children

Design outcomes

Primary

Measure	Time frame
Serum concentrations of AMH, every menstruation cycle, for 6 cycles	—

Countries

Japan

Contacts

Public ContactSatoko Osuka

Nagoya University School of Medicine Obstetrics and Gynecology

akiwase@med.nagoya-u.ac.jp052-744-2261

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026